About PharMingen
PharMingen is a company based in San Diego (United States) founded in 1994 was acquired by Becton Dickinson in May 1997. The company has 653 employees. PharMingen operates in a competitive market with competitors including Bio Rad, Siemens Healthineers, Merck, Quanterix and Biocare Medical, among others.
- Headquarter San Diego, United States
- Employees 653
- SectorsHealthcare
- Website pharmingen.com
- Acquired by Becton Dickinson (May 1997)
- Annual Revenue$164.71 M (USD)5as on Mar 31, 2024
- Net Profit$9.1 M (USD)24as on Mar 31, 2024
- EBITDA$17.4 M (USD)13as on Mar 31, 2024
- Investors
- Employee Count653
- Acquired byBecton Dickinson
(May 1997)
Associated legal entities of PharMingen
PharMingen is associated with 2 registered companies on The Company Check. Each company page carries the filings, financials, charges and directors of that entity.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2023) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Becton Dickinson Technology Campus India Llp CIN AAO-6240 | Active | 25 Mar 2019 | Bengaluru, Karnataka | ₹171 Cr | 404 | 3 | View details |
| Becton Dickinson India Private Limited. CIN U74899DL1995PTC064117 | Active | 06 Jan 1995 | New Delhi, Delhi | ₹1,621 Cr | 890 | 5 | View details |
Investors in PharMingen
PharMingen has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include BD.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
BD is recognized for providing innovative medical technology solutions. | 1897 | bd.com | Franklin Lakes, United States |
Investor details for PharMingen
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Board of directors of PharMingen
The boards of the 2 registered companies of PharMingen currently have 5 directors; the longest-serving is Puay Lian Geraldine Lim, appointed in 2021. 25 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Puay Lian Geraldine Lim DIN 09205273 | Director | 01 Jul 2021 | 5 yrs 3 mo | Becton Dickinson India Private Limited. |
| Noel Gray Harvey DIN 09330009 | Designated Partner | 28 Sep 2021 | 5 yrs | Becton Dickinson Technology Campus India Llp |
| Atul Grover DIN 05320202 | Designated Partner | 15 Mar 2023 | 3 yrs 6 mo | Becton Dickinson Technology Campus India Llp, Becton Dickinson India Private Limited. |
| Deepak Malhotra DIN 09537624 | Designated Partner | 19 Sep 2024 | 2 yrs | Becton Dickinson Technology Campus India Llp, Becton Dickinson India Private Limited. |
| Ulrich Stefer DIN 07447177 | Director | 07 Apr 2025 | 1 yr 6 mo | Becton Dickinson India Private Limited. |
Financials of PharMingen
Figures of Becton Dickinson Technology Campus India Llp, the primary company behind PharMingen, for FY 2023. Revenue was ₹171 Cr (+45% year on year). Net profit was ₹24.49 Cr (14% margin). EBITDA was ₹26.60 Cr (16% margin). Revenue has grown at a compounded annual rate of +102% over three years.
- ₹171 CrRevenue · FY 2023 · +45% YoY
- ₹24.49 CrNet profit · 14% margin
- ₹26.60 CrEBITDA · 16% margin
- 404Employees (provident fund records)
- +102%Revenue CAGR, 3 years
Balance sheet, profit and loss, cash flow and ratios of Becton Dickinson Technology Campus India Llp are on its company page.
Detailed financial statements for PharMingen
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Timeline of PharMingen
2 dated milestones of PharMingen across 3 years, from founding to its latest funding, stage changes and deals.
- Founded PharMingen is founded.
- Exit Acquired by Becton Dickinson.
Competitors of PharMingen
PharMingen operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Bio Rad, Siemens Healthineers, Merck, Quanterix and Biocare Medical, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| bio-rad.com | 1952 | Hercules, United States | – | 10 | Portfolio of products and services for life science research and clinical diagnostic markets | |
| siemens-healthineers.com | 1847 | Erlangen, Germany | – | 66,000 | AI-based medical diagnostics are developed for healthcare applications. | |
| merckgroup.com | 1668 | Darmstadt, Germany | – | 922 | Merck is engaged in science and technology solutions globally. | |
| quanterix.com | 2007 | Cambridge, United States | $99.5M | 141 | Assay kits for ultra-sensitive biomarker detection are developed. | |
| biocare.net | 1997 | Concord, United States | $85M | 161 | Primary antibodies and instruments for immunohistochemistry are manufactured. | |
| biolifesolutions.com | 1987 | Bothell, United States | – | 685 | Tissue hypothermic storage and cryopreservation freeze media are developed. | |
| apbiocode.com | 2008 | Santa Fe Springs, United States | $20.29M | 66 | Assay kits and instruments for in vitro diagnostics are developed. | |
| telesisbio.com | 2013 | San Diego, United States | $25M | – | Online platform offering life sciences reagents and kits |
Detailed competitors of PharMingen
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Similar companies to PharMingen
10 companies that operate in the same segment as PharMingen (Life Sciences Platforms & Tools), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Medidata is recognized as a leading provider of SaaS solutions for clinical research. | 1999 | New York, New York, United States | USD 41.5 M | – | – | |
AI-based solutions for health management are provided. | 2015 | Dallas, Texas, United States | USD 2.8 B | – | – | |
Nanopore-based electronic systems for single-molecule analysis are developed. | 2005 | Oxford, Oxfordshire, United Kingdom | USD 1.3 B | USD 301.49 M | 1,480 | |
Real-world health data is provided for research and decisions. | 2012 | Menlo Park, California, United States | USD 259.16 M | – | – | |
Genetically modified cell lines are developed using AAV gene-editing platform. | 2007 | Cambridge, Cambridgeshire, United Kingdom | USD 46.29 M | – | – | |
Biological reagents and antibodies are developed for life science research. | 1998 | Cambridge, Cambridgeshire, United Kingdom | USD 78.8 M | – | – | |
Electron microscopy services and microanalysis instruments are provided. | 1956 | Waltham, Massachusetts, United States | – | USD 44.56 B | 125,000 | |
Novel therapeutics are discovered using an AI-enabled drug platform. | 2013 | New York, New York, United States | USD 456.66 M | USD 74.68 M | – | |
A platform for sharing and accessing academic research papers is provided. | 2008 | San Francisco, California, United States | USD 58.4 M | – | – | |
Developer of molecular diagnostic testing solutions | 1996 | Sunnyvale, California, United States | USD 19.1 M | USD 54.88 M | 208 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about PharMingen
PharMingen was founded in 1994.
PharMingen is headquartered in San Diego, United States. It is registered at San Diego, California, United States.
PharMingen has 653 employees.
Annual revenue of PharMingen is $164.71M as on Mar 31, 2024.
PharMingen was founded in 1994 in San Diego, United States, focusing on the biotechnology sector for research tools. Operations involve the development, manufacturing, and distribution of monoclonal antibodies, their conjugates, polyclonal antibodies, protein expression systems, and recombinant proteins targeted at immunology, cell biology, and molecular biology applications. The company was acquired by Becton Dickinson Company in May 1997.
PharMingen's top competitors include Biocare Medical, Merck and Siemens Healthineers.
PharMingen has 1 investor. Key investors include BD.
PharMingen is associated with 2 legal entities: Becton Dickinson Technology Campus India Llp, Becton Dickinson India Private Limited..
Yes. PharMingen was acquired by Becton Dickinson in May 1997.
The legal entities of PharMingen currently have 6 directors, including Noel Gray Harvey, Deepak Malhotra, Atul Grover and others.